Acceptance and Commitment Therapy for Chronic Pain: What the Evidence Actually Shows

What this video covers

• Why pain that outlasts healing is best explained by changes in how the brain and spinal cord process pain, not by tissue damage alone. And why that model is still a working framework drawn from imaging and animal studies, not proven human biology
• How fear of pain leads you to avoid things, lose fitness and do less, and why disability matches only loosely with what shows on a scan
• What ACT actually does: you accept the sensation, step back from scary thoughts, and take committed action toward what you value
• The real numbers from 33 randomized trials in 2,293 patients: small-to-moderate gains in function and mood that shrink over time
• Why the 2020 Cochrane review still rates the ACT evidence very low certainty against active comparators (other real treatments), and what that means for you
• Honest risks and limits: distress can rise for a while when you stop avoiding. Pain or fatigue can flare as you step up activity. Close to 20 percent dropped out of the fibromyalgia trials. Side effects are poorly reported across the whole ACT research base. And ACT does not change the structural problem
• MEDICAL DISCLAIMER: This content is for educational purposes only and is not medical advice. It does not substitute for professional diagnosis or treatment. Always consult a licensed healthcare provider regarding your condition. Viewing this video does not establish a doctor-patient relationship.

Acceptance and Commitment Therapy (ACT) is a behavioral treatment for chronic pain built on three moves. You accept the sensation. You step back from scary thoughts (defusion). And you take committed action toward what you value. Across 33 randomized trials in 2,293 patients, it gave small-to-moderate gains in function and mood that shrink over time.

You have stopped taking the stairs. You sit in the one chair that does not make it worse. The MRI was two years ago, the first injection helped, and the fourth did not. Somewhere in there your world contracted to the recliner and the kitchen.

Here is what is missing from your chart. There is a column for morphine equivalents. There is no column for how long you can stand, how far you walked this week, or how many things you said no to. This article explains what that missing column measures and why it changes how pain feels. It also shows where Acceptance and Commitment Therapy (ACT), a behavioral treatment with real but modest trial evidence, fits in the order of care. It is an explanation, not a sales pitch. The honest version of this evidence includes a Cochrane review. That review found no statistically significant benefit when ACT was measured against another real treatment.

Why do fear and avoidance make chronic pain more disabling?

Alongside whatever your disc or joint is doing, a behavior set has been building. It is every movement, outing and duty you dropped because you tie it to a flare.

Fear and avoidance are among the best-documented correlates (companions) of disability in chronic pain. Prospective studies, which follow people forward, agree: they track disability better than imaging does. Be exact about what that means. It is a strong link with a believable mechanism, not a proven cause in any one patient. Nobody measured yours. That is not because it can’t be measured; the questionnaire takes about four minutes. It is because no procedure attaches to the answer.

The mechanism, and the edge of it

Before anyone asks you to do behavioral work, you are owed the mechanism. You are also owed its limits, because here the confident version and the honest version are not the same.

Acute pain is a report. Nociceptors (the nerve endings that detect tissue threat) fire, tissue heals, and the report stops. Pain that lasts past that window looks different. The leading model describes three changes. Signals get amplified in the dorsal horn of the spinal cord. The brakes sent down from the periaqueductal gray and rostral ventromedial medulla (brainstem areas that normally turn pain down) get weaker. And threat learning builds across the amygdala, insula and cingulate cortex. In that model the nervous system is not reporting damage. It is predicting it.

That account comes from human imaging and animal work. It is the leading framework. It is not confirmed human physiology, and reciting it as fact is overselling. Proposed brain-network explanations, including default-mode-network changes, are still early. What no one disputes is narrower and more useful: disability tracks imaging poorly.

Why does chronic pain feel like damage when the scan has not changed?

This is the part that explains the lived experience rather than the diagram.

A sensation arrives. You read it as damage. You guard, and you cancel. Guarding makes you lose fitness. Lost fitness lowers your tolerance, so the next ordinary movement hurts more. And the first reading is confirmed. The loop tightens with every turn:

sensation → interpreted as damage → guarding → deconditioning → lower tolerance → confirmation

In this model, avoidance is an excellent short-term analgesic. The cohort data suggest it is a costly long-term one. That is why the stairs feel more dangerous this year than last even when the scan is unchanged, and why the flare that follows a good day feels like proof you were right to stop. It is not proof. It is deconditioning meeting an interpretation that was never tested.

What standard care misses — and what it must not skip

None of the above earns you a psychological label. You do not get to invoke central processing until you have earned it, and the way you earn it is by finishing the diagnosis.

Red flags come first. New weakness, a change in bowel or bladder control, fever, weight loss you can’t explain, night pain, or a history of cancer means imaging and lab work today, not psychology. The differential is settled with anatomy, not adjectives.

The structural question deserves a real answer. In the video, Dr. Padda notes that no history question and no exam move reliably pins the pain on the facet joints. Maas and colleagues, European Journal of Pain, 2017, put the hit rate (sensitivity) of the physical exam anywhere from eleven to one hundred percent. The answer is a low-volume medial branch block under live X-ray (fluoroscopy). The only readout is the percent of pain relieved while the numbing medicine works. Even then, false positives on a single block run twenty-seven to forty-seven percent. So one positive block is a hypothesis, not a diagnosis.

Burning numbness in both feet is a polyneuropathy until proven otherwise. The neurology practice parameter names three highest-yield screening tests. The first is a blood sugar (glucose). The second is a B12 with its byproduct methylmalonic acid, because a normal B12 can still fall short in the body. The third is a serum protein immunofixation electrophoresis to catch an abnormal blood protein (a paraprotein). If that routine glucose is not in the diabetic range, the same parameter says a glucose tolerance test may be considered. That is a deliberately weaker recommendation than the first three, and it is worth calling weaker. Dr. Padda adds a fasting insulin. That addition is his practice preference, not a guideline recommendation.

So what standard care misses cuts both ways. Symptom-control drugs and well-chosen injections do their job well. They turn down a signal. And a well-aimed diagnostic block answers a question no questionnaire can. What neither does is measure or change the behavior set. A treatable cause hiding under a psychological label is the failure in one direction. An unmeasured, untreated avoidance pattern is the failure in the other.

What is acceptance and commitment therapy, and where does it fit in pain care?

The order is the whole argument. Behavioral work goes third, never first. A program handed to a patient whose diagnosis is unfinished is not treatment; it is a way of closing the file.

1. First, the structural question gets answered and named, with a block that answers a question instead of filling a slot.
2. Second, the metabolic question, because a starved nerve does not respond to mind skills. We use ketogenic nutrition, specialized pro-resolving mediators (fats that help end inflammation), and red-light therapy (photobiomodulation) between 660 and 850 nanometers. Here, they are add-ons.
3. Third — and only third — behavioral work.

The full ACT model has six processes. In pain programs, four do most of the work:

• Acceptance: you stop fighting a sensation you cannot switch off. This is not giving in to a life sentence. It is dropping a fight that costs energy and wins nothing.
• Defusion: you watch the thought that your spine is falling apart instead of obeying it.
• Values — you name what pain has taken: the grandchild, the workbench, the mile walk.
• Committed action: you step up activity toward those things, on your schedule.

A licensed psychologist trained in pain delivers this, usually over six to twelve sessions, and never inside a procedure visit. Good candidates are adults with more than three months of pain. Three months, not a year. Their workup has ruled out nerve loss, infection, fracture and cancer. And their lives have shrunk around avoidance. The more you avoid, the more there is here for you. The trials measured benefit over three to twelve months. That is the honest horizon. If your pain is six weeks old, or the workup is unfinished, you are not a candidate today.

Does acceptance and commitment therapy work for chronic pain?

The largest summary is a three-level meta-analysis by Lai and colleagues (2023): 33 randomized trials, 2,293 patients. Right after treatment, Hedges g (a measure of effect size) was 0.44 for pain intensity and 0.59 for physical function. It was 0.43 for both depression and anxiety. Real, and modest.

Two catches matter. The first is time. Longer follow-up went with smaller effects for pain intensity and physical function. Pain intensity fell from 0.44 to 0.34, and physical function from 0.59 to 0.56. The mood numbers drifted less. Depression stayed at 0.43, and anxiety eased from 0.43 to 0.35. But “drifted less” is not “held”. Anxiety came down about as much as pain intensity did. What the analysis actually tested and found was that the pain and function benefit wore off over time. The second catch is delivery. Face-to-face ACT gave significantly larger effects than online ACT on the physical outcomes. The app is not the same product.

For fibromyalgia, Eastwood and Godfrey (2024) pooled six trials and 384 patients, mostly women. Pain acceptance improved a lot (SMD 1.05; 95% CI 0.61 to 1.49). The honest catch: this is a self-report questionnaire score in trials where people knew their treatment, and that limits how much it can carry. The impact of fibromyalgia on daily life improved too, but loosely. The SMD was −1.05, with a confidence interval of −2.02 to −0.09 that very nearly touches no effect.

Now the hardest number, the one that separates an honest article from a brochure. The 2020 Cochrane review by Williams and colleagues asked the harder question. Not whether ACT beats a waiting list, but whether it beats an active comparator: another real treatment given with equal attention. That comparison is small. Five studies, 443 patients. Pain (SMD −0.54; 95% CI −1.20 to 0.11), disability (−1.51; −3.05 to 0.03), and distress (−0.61; −1.30 to 0.07) all leaned toward ACT on paper. Not one reached statistical significance. Every confidence interval crossed zero. The evidence was graded very low certainty. The review’s authors say plainly that they are very unsure about benefit or the lack of it.

Read that correctly. Compared with doing nothing, ACT helps. Compared with another active treatment delivered with equal attention, it has not been shown to win. Very low certainty does not mean it fails; it means the trials were too small, too unblinded, and too self-reported to tell us either way. This is contested territory, and you should be told so.

What are the risks of acceptance and commitment therapy?

The risks are not zero.

• Distress rises before it falls. When you stop avoiding, grief or old trauma can come up. If you carry a post-traumatic stress diagnosis, trauma-focused treatment belongs alongside or before this work, because facing what you have avoided can briefly make trauma symptoms worse. If anxiety or post-traumatic stress is part of your picture, the clinical detail is on our page about anxiety, PTSD, and chronic pain.
• Stepping up activity often brings a short flare in pain or fatigue.
• Mood can worsen, and that warrants a phone call to your clinician rather than waiting it out.
• People drop out. Attrition in the fibromyalgia trials ran near twenty percent, and stayed under that mark in four of the six studies. At the high end that is about one patient in five who did not finish, and the safe assumption is that they did worse than the people who stayed.
• Safety is not established. The fibromyalgia review reported no side effects caused by ACT. But the Cochrane review rates side-effect reporting across this whole body of research as poor. No reported harm is not the same as proven safety.
• ACT changes nothing structural. A torn annulus is still torn.

What this means for your evaluation

If nobody has handed you a diagnosis you can name, that is the first thing to fix — not the last.

A course that goes well looks less dramatic than patients expect. The following is an illustrative composite assembled from many patients with this presentation, not one person’s chart, and the numbers in it show the shape of a good course rather than an average or a schedule to hold yourself to. An adult with axial low back pain past four years. Two surgical consultations, both declined. Medial branch blocks that were diagnostically informative, with real but finite relief. A nearly empty activity log. The first six weeks of behavioral work were worse, not better. The values work surfaced grief. There was a flare in week five that felt like proof the whole thing was a mistake. It was not proof. It was week five. In a course that goes well, the graded walk is measured in minutes by around the fourth month and in fractions of a mile by the ninth. These figures are illustrative rather than trial results. A meaningful number of patients never get there, and some of the gain that is made attenuates over time. Individual results vary.

That is not a cure, and nobody should offer you one. It is function, returned, bought with work. It sits on top of an accurate structural and metabolic diagnosis, not in place of one. If anxiety, post-traumatic stress or low mood is part of what you carry into that evaluation, our page on how anxiety, PTSD, and chronic pain interact covers that side of the workup in clinical detail.

Frequently asked questions

Key takeaways

• Alongside the structural problem, an avoidance pattern builds up. Fear and avoidance track disability better than imaging does. Still, the link is not proof of cause in any one patient.
• The idea that lasting pain comes from how the nervous system processes it is the leading framework. It comes from imaging and animal work. It is not confirmed human biology.
• ACT’s evidence is real but modest. Effects were small to moderate across 33 trials, and the pain and function gains wore off over time. The 2020 Cochrane review found no statistically significant benefit against an active comparator. It graded the evidence very low certainty.
• Risks include a rise in distress, grief or trauma coming up, flares with activity, and dropout near one in five in the fibromyalgia trials. Side-effect reporting is poor, so safety is not established.
• Behavioral work goes third, after the structural question and the metabolic question are answered. Get the diagnosis first. Then decide whether you want to do the work.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary. Do not start, stop, or change any medication without consulting your physician. To be evaluated, request an appointment at painmd.tv, call (314) 481-5000, or text (314) 886-5902.

References

1. Lai L, Liu Y, McCracken LM, Li Y, Ren Z. The efficacy of acceptance and commitment therapy for chronic pain: A three-level meta-analysis and a trial sequential analysis of randomized controlled trials. Behav Res Ther. 2023;165:104308. PMID 37043967. PubMed
2. Williams ACC, Fisher E, Hearn L, Eccleston C. Psychological therapies for the management of chronic pain (excluding headache) in adults. Cochrane Database Syst Rev. 2020;8:CD007407. PMID 32794606. PubMed
3. Eastwood F, Godfrey E. The efficacy, acceptability and safety of acceptance and commitment therapy for fibromyalgia – a systematic review and meta-analysis. Br J Pain. 2024;18(3):243-256. PMID 38751564. PubMed

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

Dr. Gurpreet Singh Padda, MD, MBA, MHP